GITR Exacerbates Lysophosphatidylcholine-induced Macrophage Pyroptosis in Sepsis Via Posttranslational Regulation of NLRP3

Overview

Journal Cell Mol Immunol

Date 2024 May 13

PMID 38740925

Authors

Siping Liang

Jinyu Zhou

Can Cao

Yiting Liu

Siqi Ming

Xi Liu

YuQi Shang

Juanfeng Lao

Qin Peng

Jiahui Yang

Minhao Wu

Affiliations

Soon will be listed here.

Abstract

The NLRP3 inflammasome functions as an inflammatory driver, but its relationship with lipid metabolic changes in early sepsis remains unclear. Here, we found that GITR expression in monocytes/macrophages was induced by lysophosphatidylcholine (LPC) and was positively correlated with the severity of sepsis. GITR is a costimulatory molecule that is mainly expressed on T cells, but its function in macrophages is largely unknown. Our in vitro data showed that GITR enhanced LPC uptake by macrophages and specifically enhanced NLRP3 inflammasome-mediated macrophage pyroptosis. Furthermore, in vivo studies using either cecal ligation and puncture (CLP) or LPS-induced sepsis models demonstrated that LPC exacerbated sepsis severity/lethality, while conditional knockout of GITR in myeloid cells or NLRP3/caspase-1/IL-1β deficiency attenuated sepsis severity/lethality. Mechanistically, GITR specifically enhanced inflammasome activation by regulating the posttranslational modification (PTM) of NLRP3. GITR competes with NLRP3 for binding to the E3 ligase MARCH7 and recruits MARCH7 to induce deacetylase SIRT2 degradation, leading to decreasing ubiquitination but increasing acetylation of NLRP3. Overall, these findings revealed a novel role of macrophage-derived GITR in regulating the PTM of NLRP3 and systemic inflammatory injury, suggesting that GITR may be a potential therapeutic target for sepsis and other inflammatory diseases. GITR exacerbates LPC-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3. According to the model, LPC levels increase during the early stage of sepsis, inducing GITR expression on macrophages. GITR not only competes with NLRP3 for binding to the E3 ligase MARCH7 but also recruits MARCH7 to induce the degradation of the deacetylase SIRT2, leading to decreasing ubiquitination but increasing acetylation of NLRP3 and therefore exacerbating LPC-induced NLRP3 inflammasome activation, macrophage pyroptosis and systemic inflammatory injury.

Citing Articles

Pyroptosis and sepsis-associated acute kidney injury.

Xiao C, Li X Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(8):1333-1340.

PMID: 39788522 PMC: 11628236. DOI: 10.11817/j.issn.1672-7347.2024.240233.

References

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

van der Poll T, van de Veerdonk F, Scicluna B, Netea M . The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017; 17(7):407-420. DOI: 10.1038/nri.2017.36. View

Samra J, Summers L, Frayn K . Sepsis and fat metabolism. Br J Surg. 1996; 83(9):1186-96. PMC: 11440814. View

Rathinam V, Fitzgerald K . Inflammasome Complexes: Emerging Mechanisms and Effector Functions. Cell. 2016; 165(4):792-800. PMC: 5503689. DOI: 10.1016/j.cell.2016.03.046. View

Mangan M, Olhava E, Roush W, Seidel H, Glick G, Latz E . Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018; 17(8):588-606. DOI: 10.1038/nrd.2018.97. View

Swanson K, Deng M, Ting J . The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019; 19(8):477-489. PMC: 7807242. DOI: 10.1038/s41577-019-0165-0. View

Song N, Liu Z, Xue W, Bai Z, Wang Q, Dai J . NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation. Mol Cell. 2017; 68(1):185-197.e6. DOI: 10.1016/j.molcel.2017.08.017. View

Niu T, De Rosny C, Chautard S, Rey A, Patoli D, Groslambert M . NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly. Nat Commun. 2021; 12(1):5862. PMC: 8494922. DOI: 10.1038/s41467-021-26142-w. View

He M, Chiang H, Luo H, Zheng Z, Qiao Q, Wang L . An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance. Cell Metab. 2020; 31(3):580-591.e5. PMC: 7104778. DOI: 10.1016/j.cmet.2020.01.009. View

10.

McHugh R, Whitters M, Piccirillo C, Young D, Shevach E, Collins M . CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002; 16(2):311-23. DOI: 10.1016/s1074-7613(02)00280-7. View

11.

Shevach E, Stephens G . The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?. Nat Rev Immunol. 2006; 6(8):613-8. DOI: 10.1038/nri1867. View

12.

Santucci L, Agostini M, Bruscoli S, Mencarelli A, Ronchetti S, Ayroldi E . GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut. 2006; 56(1):52-60. PMC: 1856662. DOI: 10.1136/gut.2006.091181. View

13.

Xiao X, Shi X, Fan Y, Zhang X, Wu M, Lan P . GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation. Nat Commun. 2015; 6:8266. PMC: 4570275. DOI: 10.1038/ncomms9266. View

14.

Sabharwal S, Rosen D, Grein J, Tedesco D, Joyce-Shaikh B, Ueda R . GITR Agonism Enhances Cellular Metabolism to Support CD8 T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model. Cancer Immunol Res. 2018; 6(10):1199-1211. DOI: 10.1158/2326-6066.CIR-17-0632. View

15.

Shami A, Atzler D, Bosmans L, Winkels H, Meiler S, Lacy M . Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans. Eur Heart J. 2020; 41(31):2938-2948. PMC: 9594689. DOI: 10.1093/eurheartj/ehaa484. View

16.

Mu X, Wang P, Wang X, Li Y, Zhao H, Li Q . Identification of a Novel Antisepsis Pathway: Sectm1a Enhances Macrophage Phagocytosis of Bacteria through Activating GITR. J Immunol. 2020; 205(6):1633-1643. PMC: 7484034. DOI: 10.4049/jimmunol.2000440. View

17.

Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z . Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015; 160(1-2):62-73. DOI: 10.1016/j.cell.2014.11.047. View

18.

Hao H, Cao L, Jiang C, Che Y, Zhang S, Takahashi S . Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis. Cell Metab. 2017; 25(4):856-867.e5. PMC: 6624427. DOI: 10.1016/j.cmet.2017.03.007. View

19.

Knee D, Hewes B, Brogdon J . Rationale for anti-GITR cancer immunotherapy. Eur J Cancer. 2016; 67:1-10. DOI: 10.1016/j.ejca.2016.06.028. View

20.

Zhu K, Baudhuin L, Hong G, WILLIAMS F, Cristina K, Kabarowski J . Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem. 2001; 276(44):41325-35. DOI: 10.1074/jbc.M008057200. View